Merck (MRK) Completes Tender Offer to Acquire Immune Design (IMDZ) Apr 2, 2019 06:46AM
Merck Completes Tender Offer to Acquire Immune Design Apr 2, 2019 06:45AM
Merck Begins Tender Offer to Acquire Immune Design Mar 5, 2019 06:45AM
Merck (MRK) to Acquire Immune Design (IMDZ) for $5.85/Share Feb 21, 2019 06:45AM
Merck to Acquire Immune Design Feb 21, 2019 06:45AM


Jun 22, 2016 07:30AM Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
Aug 10, 2015 08:00AM Immune Design and Merck to Collaborate on Combination Trials of Two Immune Design Immunotherapies With Merck's KEYTRUDA for Non-Hodgkin's Lymphoma and Melanoma
Aug 10, 2015 08:00AM Immune Design and Merck to Collaborate on Combination Trials of Two Immune Design Immunotherapies With Merck's KEYTRUDA for Non-Hodgkin's Lymphoma and Melanoma